Delivery Order SPE2DB20D1100-SPE2DB25FD7J8
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at two hundred thirty-four dollars to Amerisourcebergen Drug Corporation for the provision of 4562004320 Lurasidone hydrochloride 40mg tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver 30 tablets to an address in Conshohocken, Pennsylvania between August 31, 2023 and September 1, 2023. The Defense Logistics Agency is the funding agency for this order placed under an existing...
- The Defense Logistics Agency awarded a $196.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120mg Lurasidone HCL tablets. As the prime contractor, Amerisourcebergen will deliver 30 tablets to an address in Conshohocken, Pennsylvania, fulfilling the agency's requirements under the contract by August 2, 2023 after a start date of August 1. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical distribution vehicles to supply...
- The Defense Logistics Agency awarded a $170,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30 boxes containing 40mg tablets of Lurasidone HCl. The order is to be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania by July 21, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this order for the antipsychotic drug Lurasidone HCl is likely to support...
- The Defense Logistics Agency Troop Support Medical awarded a $136,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 boxes containing 80mg Lurasidone HCl tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 19-20, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency manages the global supply chain for the United States Department of...
- The Defense Logistics Agency awarded a $349,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60mg Lurasidone HCL tablets. The order is for 20 tablets to be delivered to the prime contractor's facility in Conshohocken, Pennsylvania by June 30, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations, suggesting this order for pharmaceutical supplies supports DOD healthcare programs. No additional subcontractors or set aside...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $278.20 to Amerisourcebergen Drug Corp for the supply of 4562122708 LURASIDONE HCL 20 MG TABLET 30S. The prime contractor, Amerisourcebergen Drug Corp, is a division of Amerisourcebergen Corporation and will perform under the contract from its location in Conshohocken, Pennsylvania. The delivery order was awarded on September 11, 2023 under an existing DLA contract vehicle and is scheduled for completion by...
- The Defense Logistics Agency awarded a $222.46 delivery order to Amerisourcebergen Drug Corp for 4561723591 LURASIDONE HCL 40 MG TABLET 30S. The prime contractor, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 8, 2023 under a firm fixed price contract. No set aside designation or subcontractors were indicated. The Defense Logistics Agency routinely procures pharmaceuticals and other medical supplies to...
- <p>Amerisourcebergen Drug Corp has been awarded a one hundred twenty-one dollar firm fixed price delivery order against an unidentified contract vehicle to supply Lurasidone HCL 120 MG tablets to the Defense Logistics Agency Troop Support Medical. The order was awarded on October 16, 2023 and requires delivery by October 17, 2023. Performance will take place in Conshohocken, Pennsylvania. No set-aside provisions were applied to this procurement.</p>
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at one hundred one dollars and fifty-two cents ($101.52) by the Defense Logistics Agency of the Department of Defense. The firm fixed price order is for the delivery of thirty (30) 60mg tablets of Lurasidone HCl to a location in Conshohocken, Pennsylvania. Performance will take place between August 22nd and 23rd, 2023. No set aside designation or subcontracting details were...
- This federal contract award, SPE2DB20D7059|SPE2DB25FQBM3, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lurasidone HCL 20 mg tablets, a medication used to treat mental health conditions. The contract has a ceiling value of $2,716.12 and runs through March 12, 2025. This contract is a delivery order and is priced as a firm fixed price. AmerisourceBergen Drug...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD7J8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,731.77 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Lurasidone HCl 120 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with performance scheduled for completion by July 31, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. Lurasidone is an atypical antipsychotic medication commonly used in the treatment of schizophrenia and bipolar depression within military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains a demonstrated capability to fulfill competitive federal procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 7/30/25 |